Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 12 February 1993:
Vol. 259. no. 5097, pp. 968 - 971
DOI: 10.1126/science.8438156
Prev | Table of Contents | Next

Articles

Science, Vol 259, Issue 5097, 968-971
Copyright © 1993 by American Association for the Advancement of Science

articles

Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia

CL Willman, CE Sever, MG Pallavicini, H Harada, N Tanaka, ML Slovak, H Yamamoto, K Harada, TC Meeker, AF List, and al. et

University of New Mexico School of Medicine, Department of Pathology, Albuquerque 87131.

One of the most frequent cytogenetic abnormalities in human leukemia and myelodysplasia is an interstitial deletion within chromosome 5q. A tumor suppressor gene has been hypothesized to lie in 5q31, the smallest commonly deleted region. IRF-1, a gene whose product manifests anti-oncogenic activity, was mapped to 5q31.1. IRF-1 lies between IL-5 and CDC25C and is centromeric to IL-3 and GM-CSF. Among these genes, only IRF-1 was consistently deleted at one or both alleles in 13 cases of leukemia or myelodysplasia with aberrations of 5q31. Inactivating rearrangements of one IRF-1 allele, accompanied by deletion of the second allele, were also identified in one case of acute leukemia. Thus, IRF-1 may be a critically deleted gene in human leukemia and myelodysplasia.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Cooperative Regulation of the Interferon Regulatory Factor-1 Tumor Suppressor Protein by Core Components of the Molecular Chaperone Machinery.
V. Narayan, M. Eckert, A. Zylicz, M. Zylicz, and K. L. Ball (2009)
J. Biol. Chem. 284, 25889-25899
   Abstract »    Full Text »    PDF »
Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1.
M. J. Lace, J. R. Anson, A. J. Klingelhutz, H. Harada, T. Taniguchi, A. D. Bossler, T. H. Haugen, and L. P. Turek (2009)
Carcinogenesis 30, 1336-1344
   Abstract »    Full Text »    PDF »
Molecular classification of spontaneous endometrial adenocarcinomas in BDII rats.
E. Samuelson, C. Hedberg, S. Nilsson, and A. Behboudi (2009)
Endocr. Relat. Cancer 16, 99-111
   Abstract »    Full Text »    PDF »
AML1/RUNX1 Works as a Negative Regulator of c-Mpl in Hematopoietic Stem Cells.
Y. Satoh, I. Matsumura, H. Tanaka, S. Ezoe, K. Fukushima, M. Tokunaga, M. Yasumi, H. Shibayama, M. Mizuki, T. Era, et al. (2008)
J. Biol. Chem. 283, 30045-30056
   Abstract »    Full Text »    PDF »
Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis.
J. Park, K. Kim, E.-J. Lee, Y.-J. Seo, S.-N. Lim, K. Park, S. B. Rho, S.-H. Lee, and J.-H. Lee (2007)
PNAS 104, 17028-17033
   Abstract »    Full Text »    PDF »
Tumor Suppressive Protein Gene Associated with Retinoid-Interferon-Induced Mortality (GRIM)-19 Inhibits src-Induced Oncogenic Transformation at Multiple Levels.
S. Kalakonda, S. C. Nallar, P. Gong, D. J. Lindner, S. E. Goldblum, S. P. Reddy, and D. V. Kalvakolanu (2007)
Am. J. Pathol. 171, 1352-1368
   Abstract »    Full Text »    PDF »
RIL, a LIM Gene on 5q31, Is Silenced by Methylation in Cancer and Sensitizes Cancer Cells to Apoptosis.
Y. A. Boumber, Y. Kondo, X. Chen, L. Shen, V. Gharibyan, K. Konishi, E. Estey, H. Kantarjian, G. Garcia-Manero, and J.-P. J. Issa (2007)
Cancer Res. 67, 1997-2005
   Abstract »    Full Text »    PDF »
17{beta}-Estradiol downregulates interferon regulatory factor-1 in murine splenocytes.
A. J Lengi, R. A Phillips, E. Karpuzoglu, and S. A. Ahmed (2006)
J. Mol. Endocrinol. 37, 421-432
   Abstract »    Full Text »    PDF »
Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action.
M. A. Garcia, J. Gil, I. Ventoso, S. Guerra, E. Domingo, C. Rivas, and M. Esteban (2006)
Microbiol. Mol. Biol. Rev. 70, 1032-1060
   Abstract »    Full Text »    PDF »
A Novel Repressor Domain Is Required for Maximal Growth Inhibition by the IRF-1 Tumor Suppressor.
M. Eckert, S. E. M. Meek, and K. L. Ball (2006)
J. Biol. Chem. 281, 23092-23102
   Abstract »    Full Text »    PDF »
N-Ras-Induced Growth Suppression of Myeloid Cells Is Mediated by IRF-1.
T. Passioura, A. Dolnikov, S. Shen, and G. Symonds (2005)
Cancer Res. 65, 797-804
   Abstract »    Full Text »    PDF »
Interferon Regulatory Factor 7 Is Associated with Epstein-Barr Virus-Transformed Central Nervous System Lymphoma and Has Oncogenic Properties.
L. Zhang, J. Zhang, Q. Lambert, C. J. Der, L. Del Valle, J. Miklossy, K. Khalili, Y. Zhou, and J. S. Pagano (2004)
J. Virol. 78, 12987-12995
   Abstract »    Full Text »    PDF »
Interferon Regulatory Factor 1 Binding to p300 Stimulates DNA-Dependent Acetylation of p53.
D. Dornan, M. Eckert, M. Wallace, H. Shimizu, E. Ramsay, T. R. Hupp, and K. L. Ball (2004)
Mol. Cell. Biol. 24, 10083-10098
   Abstract »    Full Text »    PDF »
Lysyl Oxidase Is a Tumor Suppressor Gene Inactivated by Methylation and Loss of Heterozygosity in Human Gastric Cancers.
A. Kaneda, K. Wakazono, T. Tsukamoto, N. Watanabe, Y. Yagi, M. Tatematsu, M. Kaminishi, T. Sugimura, and T. Ushijima (2004)
Cancer Res. 64, 6410-6415
   Abstract »    Full Text »    PDF »
Interferon Regulatory Factor-1 Mediates the Proapoptotic but Not Cell Cycle Arrest Effects of the Steroidal Antiestrogen ICI 182,780 (Faslodex, Fulvestrant).
K. B. Bouker, T. C. Skaar, D. R. Fernandez, K. A. O'Brien, R. B. Riggins, D. Cao, and R. Clarke (2004)
Cancer Res. 64, 4030-4039
   Abstract »    Full Text »    PDF »
Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression.
S Giannouli, D Tzoanopoulos, K Ritis, G Kartalis, H M Moutsopoulos, and M Voulgarelis (2004)
Ann Rheum Dis 63, 578-582
   Abstract »    Full Text »    PDF »
Mullerian Inhibiting Substance Promotes Interferon {gamma}-induced Gene Expression and Apoptosis in Breast Cancer Cells.
Y. Hoshiya, V. Gupta, H. Kawakubo, E. Brachtel, J. L. Carey, L. Sasur, A. Scott, P. K. Donahoe, and S. Maheswaran (2003)
J. Biol. Chem. 278, 51703-51712
   Abstract »    Full Text »    PDF »
The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3.
J. Zhang, J. Yang, S. K. Roy, S. Tininini, J. Hu, J. F. Bromberg, V. Poli, G. R. Stark, and D. V. Kalvakolanu (2003)
PNAS 100, 9342-9347
   Abstract »    Full Text »    PDF »
Molecular Mechanisms of Myelodysplastic Syndrome.
H. Hirai (2003)
Jpn. J. Clin. Oncol. 33, 153-160
   Abstract »    Full Text »    PDF »
A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia.
R. Wessely, L. Hengst, B. Jaschke, F. Wegener, T. Richter, R. Lupetti, M. Paschalidis, A. Schomig, R. Brandl, and F.-J. Neumann (2003)
Hum. Mol. Genet. 12, 177-187
   Abstract »    Full Text »    PDF »
Thioredoxin Reductase Plays a Critical Role in IFN Retinoid-mediated Tumor-Growth Control in Vivo.
D. J. Lindner, X. Ma, J. Hu, S. Karra, and D. V. Kalvakolanu (2002)
Clin. Cancer Res. 8, 3210-3218
   Abstract »    Full Text »    PDF »
Mutational Analysis of Human Thioredoxin Reductase 1. EFFECTS ON p53-MEDIATED GENE EXPRESSION AND INTERFERON AND RETINOIC ACID-INDUCED CELL DEATH.
X. Ma, J. Hu, D. J. Lindner, and D. V. Kalvakolanu (2002)
J. Biol. Chem. 277, 22460-22468
   Abstract »    Full Text »    PDF »
A Novel Interferon Regulatory Factor (IRF), IRF-10, Has a Unique Role in Immune Defense and Is Induced by the v-Rel Oncoprotein.
J. Nehyba, R. Hrdlickova, J. Burnside, and H. R. Bose Jr. (2002)
Mol. Cell. Biol. 22, 3942-3957
   Abstract »    Full Text »    PDF »
Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies.
T. X. Liu, Y. Zhou, J. P. Kanki, M. Deng, J. Rhodes, H. W. Yang, X. M. Sheng, L. I. Zon, and A. T. Look (2002)
PNAS 99, 6136-6141
   Abstract »    Full Text »    PDF »
Growth Suppression of the Hepatocellular Carcinoma Cell Line Hepa1-6 by an Activatable Interferon Regulatory Factor-1 in Mice.
A. Kröger, D. Ortmann, T. U. Krohne, L. Mohr, H. E. Blum, H. Hauser, and M. Geissler (2001)
Cancer Res. 61, 2609-2617
   Abstract »    Full Text »
Identification of a Novel Cytokine Response Element in the Human IFN Regulatory Factor-1 Gene Promoter.
D. Imanishi, K. Yamamoto, H. Tsushima, Y. Miyazaki, K. Kuriyama, M. Tomonaga, and T. Matsuyama (2000)
J. Immunol. 165, 3907-3916
   Abstract »    Full Text »    PDF »
The IRF-3 Transcription Factor Mediates Sendai Virus-Induced Apoptosis.
C. Heylbroeck, S. Balachandran, M. J. Servant, C. DeLuca, G. N. Barber, R. Lin, and J. Hiscott (2000)
J. Virol. 74, 3781-3792
   Abstract »    Full Text »
Genetic localization of an autosomal dominant leukodystrophy mimicking chronic progressive multiple sclerosis to chromosome 5q31.
C. M. Coffeen, C. E. McKenna, A. H. Koeppen, N. M. Plaster, N. Maragakis, J. Mihalopoulos, J. D. Schwankhaus, K. M. Flanigan, R. G. Gregg, L. J. Ptacek, et al. (2000)
Hum. Mol. Genet. 9, 787-793
   Abstract »    Full Text »    PDF »
Achievements in Understanding and Treatment of Myelodysplastic Syndromes.
E. Hellstrom-Lindberg, C. Willman, A. J. Barrett, and Y. Saunthararajah (2000)
Hematology 2000, 110-132
   Abstract »    Full Text »    PDF »
Recruitment of CREB-Binding Protein by PU.1, IFN-Regulatory Factor-1, and the IFN Consensus Sequence-Binding Protein Is Necessary for IFN-{gamma}-Induced p67phox and gp91phox Expression.
E. A. Eklund and R. Kakar (1999)
J. Immunol. 163, 6095-6105
   Abstract »    Full Text »    PDF »
Activation of Interferon Regulatory Factor 3 in Response to DNA-damaging Agents.
T. Kim, T. Y. Kim, Y.-H. Song, I. M. Min, J. Yim, and T. K. Kim (1999)
J. Biol. Chem. 274, 30686-30689
   Abstract »    Full Text »    PDF »
Functional Analysis of Human Herpesvirus 8-Encoded Viral Interferon Regulatory Factor 1 and Its Association with Cellular Interferon Regulatory Factors and p300.
L. Burysek, W.-S. Yeow, B. Lubyová, M. Kellum, S. L. Schafer, Y. Q. Huang, and P. M. Pitha (1999)
J. Virol. 73, 7334-7342
   Abstract »    Full Text »
Identification of NKIAMRE, the Human Homologue to the Mitogen-activated Protein Kinase-/Cyclin-dependent Kinase-related Protein Kinase NKIATRE, and Its Loss in Leukemic Blasts with Chromosome Arm 5q Deletion.
M. Midmer, R. Haq, J. A. Squire, and B. W. Zanke (1999)
Cancer Res. 59, 4069-4074
   Abstract »    Full Text »    PDF »
Myelodysplasia.
M. L. Heaney and D. W. Golde (1999)
N. Engl. J. Med. 340, 1649-1660
   Full Text »    PDF »
Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53.
H. Nozawa, E. Oda, K. Nakao, M. Ishihara, S. Ueda, T. Yokochi, K. Ogasawara, Y. Nakatsuru, S. Shimizu, Y. Ohira, et al. (1999)
Genes & Dev. 13, 1240-1245
   Abstract »    Full Text »
Altered Immune Response of Interferon Regulatory Factor 1-Deficient Mice against Plasmodium berghei Blood-Stage Malaria Infection.
R. S.-P. Tan, C. Feng, Y. Asano, and A. U. Kara (1999)
Infect. Immun. 67, 2277-2283
   Abstract »    Full Text »    PDF »
Retinoic Acid Is Able to Induce Interferon Regulatory Factor 1 in Squamous Carcinoma Cells via a STAT-1 Independent Signalling Pathway.
Z. A. Percario, V. Giandomenico, G. Fiorucci, M. V. Chiantore, S. Vannucchi, J. Hiscott, E. Affabris, and G. Romeo (1999)
Cell Growth Differ. 10, 263-270
   Abstract »    Full Text »
Genetic analysis of hemopoietic cell cycling in mice suggests its involvement in organismal life span.
G. DE HAAN and G. VAN ZANT (1999)
FASEB J 13, 707-713
   Abstract »    Full Text »
Transcription Factor IRF-1 and Its Family Members in the Regulation of Host Defense.
T. TANIGUCHI, N. TANAKA, K. OGASAWARA, S. TAKI, M. SATO, and A. TAKAOKA (1999)
Cold Spring Harb Symp Quant Biol 64, 465-472
   Abstract »    PDF »
Thioredoxin Reductase Mediates Cell Death Effects of the Combination of Beta Interferon and Retinoic Acid.
E. R. Hofman, M. Boyanapalli, D. J. Lindner, X. Weihua, B. A. Hassel, R. Jagus, P. L. Gutierrez, and D. V. Kalvakolanu (1998)
Mol. Cell. Biol. 18, 6493-6504
   Abstract »    Full Text »
Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias.
M. Schmidt, S. Nagel, J. Proba, C. Thiede, M. Ritter, J. F. Waring, F. Rosenbauer, D. Huhn, B. Wittig, I. Horak, et al. (1998)
Blood 91, 22-29
   Abstract »    Full Text »    PDF »
Binding of the Transcription Factor Interferon Regulatory Factor-1 to the Inducible Nitric-oxide Synthase Promoter.
J. Spink and T. Evans (1997)
J. Biol. Chem. 272, 24417-24425
   Abstract »    Full Text »    PDF »
Intrinsic and Extrinsic Control of Hemopoietic Stem Cell Numbers: Mapping of a Stem Cell Gene.
G. d. Haan and G. V. Zant (1997)
J. Exp. Med. 186, 529-536
   Abstract »    Full Text »    PDF »
New Advances in Interferon Therapy of Cancer.
S. Wadler and E. L. Schwartz (1997)
Oncologist 2, 254-267
   Abstract »    Full Text »    PDF »
Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.
N. Zhao, A. Stoffel, P. W. Wang, J. D. Eisenbart, R. Espinosa III, R. A. Larson, and M. M. Le Beau (1997)
PNAS 94, 6948-6953
   Abstract »    Full Text »    PDF »
Interferon Regulatory Factor-1 Up-regulates Angiotensin II Type 2 Receptor and Induces Apoptosis.
M. Horiuchi, T. Yamada, W. Hayashida, and V. J. Dzau (1997)
J. Biol. Chem. 272, 11952-11958
   Abstract »    Full Text »    PDF »
Phosphorylation Events Modulate the Ability of Interferon Consensus Sequence Binding Protein to Interact with Interferon Regulatory Factors and to Bind DNA.
R. Sharf, D. Meraro, A. Azriel, A. M. Thornton, K. Ozato, E. F. Petricoin, A. C. Larner, F. Schaper, H. Hauser, and B.-Z. Levi (1997)
J. Biol. Chem. 272, 9785-9792
   Abstract »    Full Text »    PDF »
Identification of a conserved family of Meis1-related homeobox genes..
S Steelman, J J Moskow, K Muzynski, C North, T Druck, J C Montgomery, K Huebner, I O Daar, and A M Buchberg (1997)
Genome Res. 7, 142-156
   Abstract »    PDF »
Interferon Regulatory Factor-2 Directs Transcription from the gp91phox Promoter.
W. Luo and D. G. Skalnik (1996)
J. Biol. Chem. 271, 23445-23451
   Abstract »    Full Text »    PDF »
Involvement of the IRF-1 transcription factor in antiviral responses to interferons.
T Kimura, K Nakayama, J Penninger, M Kitagawa, H Harada, T Matsuyama, N Tanaka, R Kamijo, J Vilcek, T. Mak, et al. (1994)
Science 264, 1921-1924
   Abstract »    PDF »
Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations.
D. Marsh, J. Neely, D. Breazeale, B Ghosh, L. Freidhoff, E Ehrlich-Kautzky, C Schou, G Krishnaswamy, and T. Beaty (1994)
Science 264, 1152-1156
   Abstract »    PDF »
Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2.
H Harada, M Kitagawa, N Tanaka, H Yamamoto, K Harada, M Ishihara, and T Taniguchi (1993)
Science 259, 971-974
   Abstract »
The Cell Cycle Control Element of Histone H4 Gene Transcription Is Maximally Responsive to Interferon Regulatory Factor Pairs IRF-1/IRF-3 and IRF-1/IRF-7.
R. Xie, A. J. van Wijnen, C. van der Meijden, M. X. Luong, J. L. Stein, and G. S. Stein (2001)
J. Biol. Chem. 276, 18624-18632
   Abstract »    Full Text »    PDF »
Regulation of Interferon and Retinoic Acid-induced Cell Death Activation through Thioredoxin Reductase.
X. Ma, S. Karra, W. Guo, D. J. Lindner, J. Hu, J. E. Angell, E. R. Hofmann, S. P. M. Reddy, and D. V. Kalvakolanu (2001)
J. Biol. Chem. 276, 24843-24854
   Abstract »    Full Text »    PDF »
Inositol Hexakisphosphate Kinase 2 Mediates Growth Suppressive and Apoptotic Effects of Interferon-beta in Ovarian Carcinoma Cells.
B. H. Morrison, J. A. Bauer, D. V. Kalvakolanu, and D. J. Lindner (2001)
J. Biol. Chem. 276, 24965-24970
   Abstract »    Full Text »    PDF »
The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q.
A. Borkhardt, S. Bojesen, O. A. Haas, U. Fuchs, D. Bartelheimer, I. F. Loncarevic, R. M. Bohle, J. Harbott, R. Repp, U. Jaeger, et al. (2000)
PNAS 97, 9168-9173
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)